Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection technology ...

The patented platform combines genome sequencing, methylation analysis and machine learning to detect cancer and identify its ...

Reliance’s Strand Life Sciences patents a blood-based technology for early cancer detection, enhancing accuracy and accessibility.

Reliance's Strand Life Sciences patents a liquid biopsy platform for early cancer detection using AI and cfDNA analysis in ...

Reliance's Strand Life Sciences has been granted an Indian patent for its platform enabling early cancer detection from a ...

While AI holds the promise of radically transforming KM, human oversight takes on intensified responsibilities for ensuring the knowledge provided is accurate, timely, and relevant as well as guarding ...

A comparison of eight AI-powered requirements management platforms for 2026, from NLP-based quality analysis and automated test generation to live traceability scoring, covering Jama Connect, IBM ...

The seven companies listed here cover the realistic range of what a buyer will encounter in 2026: embedded ML teams that own ...

Whilst the adoption of AI tools in our workplaces definitely hasn't taken place overnight, it's easy enough to feel like the ...

The most important AI chart for startups may not be the one showing larger models, higher benchmark scores or billion-dollar training runs. It may be the one ...

Strand Life Sciences, a subsidiary of Reliance Industries Limited, today announced the grant of an Indian patent covering its integrated platform for early cancer detection using cell-free DNA (cfDNA) ...